Biological Markers of Breast Cancer: A Review

References

• Silvestrini R, Daidone MG, Di Fronzo G. Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer 1979; 44(2)655–670
   Web of Science ®Google Scholar
• Smith DC, Crawford D, Laing L, Leake RE. The prognostic significance of nuclear estrogen receptors in biopsy specimens of primary breast cancers. Br J Cancer 1979; 40: 313
   Web of Science ®Google Scholar
• Hoehn JL, Plotka ED, Dickson KB. Comparison of estrogen receptor levels in primary and regional metastatic carcinoma of the breast. Ann Surg 1979; 190: 69–71
   PubMed Web of Science ®Google Scholar
• Everson RB, Lippman ME, Thompson EB, et al. Clinical correlations of steroid receptors and male breast cancer. Cancer Res 1980; 40: 991–997
   PubMed Web of Science ®Google Scholar
• Holdaway IM, Mountjoy KG, Harvey VJ, et al. Clinical applications of receptor measurements in breast cancer. Br Med J 1980; 41: 136–139
   Google Scholar
• Barnes DM, Skinner LG, Ribeiro GG. Triple hormone receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer. Br J Cancer 1979; 40: 362–865
   Web of Science ®Google Scholar
• Borjesson BW, Sarfaty G. Estradiol receptors in subpopulations of breast cancer cells isolated from human primary tumors (meeting abstract). Cancer TreaI Rep 1979; 63: 1149
   Web of Science ®Google Scholar
• Ben F, Karl HJ. Comparison of dextran coated charcoal absorption technique (DCA) and agar gel electrophoresis (AE) for determination of estrogen receptor (ER) content of porcine uteri and human breast cancer (meeting abstract). Cancer Treat Rep 1979; 63: 1145
   Google Scholar
• Shafie S, Brooks SC. Characteristics of the dextran coated charcoal assay for estradiol receptor in breast cancer preparations. J Lab Clin Med 1979; 94: 784–798
   PubMed Web of Science ®Google Scholar
• Collings JR, Savage N. Peroxidase as a marker for estrogen dependence in human breast cancer. Br J Cancer 1979; 40: 500–503
   PubMed Web of Science ®Google Scholar
• Singh P, Murugesan K, Kapur MM, Laumas KR. Androgen receptor in breast tissues. I. A new approach for the estimation of androgen receptors in the normal and cancerow mammary gland of women. J Steroid Biochem 1979; 11: 1619–1628
   PubMedGoogle Scholar
• National Cancer Institute. NIH Consensus Development Conference Summary 1979; 2: l–3
   Google Scholar
• Contesso G, Delarue JC, Mouriesse H, et al. Anatomopathology of breast cancer and hormone receptors. Pathol Biol (Paris) 1983; 31: 741–154
   PubMedGoogle Scholar
• de la Monte SM, Hutchins GM, Moore GW. Estrogen and progesterone receptors in prediction of metastatic behavior of breast carcinoma. Am J Med 1984; 76: 11–17
   PubMed Web of Science ®Google Scholar
• Patel JK, Nemoto T, Dao TL. Is medullary carcinoma of the breast hormone dependent?. J Surg Oncol 1983; 24: 290–291
   PubMed Web of Science ®Google Scholar
• Locher GW, Davis B, Zava DT, et al. Intratumoral regional differences in hormone receptor status of breast cancer. Geburtshilfe Fraunheilkd 1984; 44: 304–306
   PubMed Web of Science ®Google Scholar
• Gross GE, Clark GM, Chamness GC, McGuire WL. Multiple progesterone receptor assays in human breast cancer. Cancer Res 1984; 44: 836–840
   PubMed Web of Science ®Google Scholar
• Etzrodt A, Jung H, Schweissfurth C, et al. Relation of steroid hormone, receptors to axillary lymph node metastasis in breast carcinoma. Gebultshilfe Fraunheilkd 1983; 43: 726–731
   PubMed Web of Science ®Google Scholar
• Dell'Anna B, Percudani M, Salvadori C. CEA and breast neoplasms: Application of personal method for determination of CEA in the clinical study of 242 patients. Bull Cancer (Paris) 1979; 66: 259–267
   PubMed Web of Science ®Google Scholar
• Brandau H, Caffier H. Phosphohexoseisomerase and carcinoembryonic antigen during the course of metastatic breast cancer following chemothrapy (meeting abstract). Cancer Treat Rep 1979; 63: 1211
   Google Scholar
• Ardiet C, Fontaniere B, Clavel M, . Breast cancer cerebromeningeal metastases: A comparison of the diagnostic values of CEA determination and cytological examination of cerebro-spinal fluid. Carcino-Embryonic Proteins: Chemistry, Biology. Clinical Applications, FG. Lehmnn, et al. Elsevier/North Holland Biomedical Press, New York 1979; 147–150
   Google Scholar
• Jakesz R, Kolb R, Reiner G, . The relationship between CEA-serum level and CEA-content in tumors of the human breast. Carcino-Embrymic Proteins: Chemistry, Biology. Clinical Applications, FG. Lehmann, et al. Elsevier/North Holland Biomedical Press, New York 1979; 127–132
   Google Scholar
• Lamerz R, Leophardt A, Ehrhart H, Lieven HV. CEA as a monitor of metastatic breast cancer. Carcino-Embryonic Proteins: Chemistry. Biology, Clinical Applications, FG. Lehmann. Elsevier/North Holland Biomedical Press, New York 1979; 139–145
   Google Scholar
• Chatal JF, Chupin F, Godin O, et al. Early detection of relapses in high risk breast cancer patients by serial CEA assays (meeting abstract). Abstracts of the 5th Annual Meeting of the Medical Oncology Society, NiceFrance. Excerpta Medic, Amsterdam 1979; 13
   Google Scholar
• Myers RE, Sutherland DJ, Meakin JW, . Prognostic value of post-operative blood levels of carcinoembryonic antigen (CEA) in breast cancer. Carcino-Embryonic Proteins: Chemistry, Biology, Clinical Applications, FG. Lehrnann, et al. Elsevierl North Holland Biomedical Press, New York 1979; 133–138
   Google Scholar
• Wahren B, Lidbrink E. Carcinoembryonic antigen content in mammary carcinoma cells. Carcino-Embryonic Proteins: Chemistry. Biology. Clinical Applications, FG. Lehmann. Elsevier/North Holland Biomedical Press, New York 1979; 121–125
   Google Scholar
• Coombes RC. Biochemical markers in breast cancer. Breast Cancer Management: The Experience of the Combined Breast Clinic, St. George's Hospital/The Royal Marsden Hospital, R. Coombes, R. Powles, C. Ford, J. Gazet. Academic Press, London 1981; 1–317
   Google Scholar
• Bjorklund V, Bjorklund B, Wittekind C, Von Kleist S. Immuno-histochemical localization of tissue polypepide antigen and carcinoembryonic antigen in breast cancer: a comparative study. Acta Pathol Microbiol Immunol Scand 1982; 90: 471–476
   Google Scholar
• Fourrier E, Kadouche J, Mignot L, et al. A simultaneous study of five markers in 80 cases of breast cancer. CEA, ferritin, beta 2 microglobulin, sub-unit beta of chorionic gonadotrophin hormone and alpha fetoprotein. Gynecologie 1981; 32: 385–390
   Google Scholar
• Silva JS, Leight GS, Haagensen DE, et al. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and CEA. Cancer 1982; 49: 1236–1242
   PubMed Web of Science ®Google Scholar
• Gugliotta P, Botta G, Bussolati G. Immunocytochemical detection of tumour markers in bone metastases from carcinoma of the breast. Histochem J 1981; 13: 953–959
   PubMedGoogle Scholar
• Vose BM, Hughes R, Bazill GW. Failure of leukocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases. Br J Cancer 1979; 40: 954–956
   PubMed Web of Science ®Google Scholar
• Vose BM, Moore M. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumors. Int. J Cancer 1979; 24: 579–585
   Web of Science ®Google Scholar
• Fritze D, Schulte-Uentrop C, Kaufmann M. Leukocyte adherence inhibition (LAI) tests in patients clinically suspected having breast cancer using a panel of breast carcinoma extracts. Eur J Cancer 1979; 15: 1491–1496
   PubMed Web of Science ®Google Scholar
• Fritze D, Schulte-Uentrop C, Kaufmann M. Detection of effector and suppressor cell-like activity in breast cancer patients by leukocyte adherence inhibition (LAI) test (meeting abstract). Abstracts of the 5th meeting of the European Association for Cancer Research. 1979, 45
   Google Scholar
• Black MM, Zachrau RE. Direct leukocyte migration test ILMT) versus cryostat sections of autologous breast cancer tissues. Compendium of Assays for Immundiagnosis of Human Cancer Development in Cancer Research, RB. Herherman. Elsevier/North Holland Biomedical Press, New York 1979; 419–422
   Google Scholar
• McCoy JL, Cannon GB, Dean JH, Herberman RB. Direct capillary tube leukocyte migration inhibition. Compendium of Assays for Immunodiagnosis of Human Cancer Development in Cancer Research, RB. Herberman. Elsevier/North Holland Biomedical Press, New York 1979; 431–437
   Google Scholar
• Dean JH, Cannon GB, Jerrells TR, . Indirect agarose micro-droplet leukocyte migration inhibition (ILMI) assay. Compendium of Assays for Immunodiagnosis of Human Cancer Development in Cancer Research, RB. Herberman, et al. Elsevier/North Holland Biomedical Press, New York 1979; 439–448
   Google Scholar
• Oldham RK. Agarose leukocyte migration inhibition (IMI). Compendium of Assays for Immunodiagnosis of Human Cancer Development in Cancer Research, RB. Herberman. Elsevier/North Holland Biomedical Press, New York 1979; 449–455
   Google Scholar
• Anderson WL, Tomasi TB. Immunosuppression in neoplasia. The Handbook of Cancer Immunology. Immune Function and Dysfunction in Relation to Cancer, H. Waters. Garland STPM Press, New York 1981; Volume 7: 1–372
   Google Scholar
• Stutman O. Immunological surveillance and cancer. The Handbook of Cancer Immunology. Immune Function and Dysfunction in Relation to Cancer, H. Waters. Garland STPM Press, New York 1981; Volume 7: 1–372
   Google Scholar
• Codington JF. The masking of cancer cell surface antigens. The Handbook of Cancer Immunology. Tumor Antigens: Structure and Function, H. Waters. Garland STPM Press, New York 1981; Volume 8.: 1–418
   Google Scholar
• Thompson K. Cell surface modulation in mammary cancer. The Handbook of Cancer Immunology. Tumor Antigens. Structure and Function, H. Waters. Garland STPM Press, New York 1981; Volume 8: 1–418
   Google Scholar
• Sanner T, Kotlar HK, Eker P, et al. Early detection of breast cancer by leukocyte adherence inhibition assay. Cancer Detect Prev 1983; 6: 443–450
   PubMedGoogle Scholar
• Tsang PH, Holland JF, Bekesi JG. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer. J Clin Lab Immunol 1982; 9: 151–157
   PubMedGoogle Scholar
• Krieger G, Kehl A, Wander HE, et al. Clinical significance of circulating immune complexes in patients with metastatic breast cancer. Int J Cancer 1983; 31: 207–211
   PubMed Web of Science ®Google Scholar
• Black MM, Zachrau RE, Shore B. Leukocyte migration test vs gp55 of RIII-MuMTV. Compendium of Assays for Immunodiagnosis of Human Cancer Development in Cancer Research, RB. Herberman. Elsevier/North Holland Biomedical Press, New York 1979; 423–430
   Google Scholar
• McCoy JL, Ames R, Braatz J, et al. Cellular immunity to mouse mammary tumor virus (MTV) in breast cancer patients (meeting abstract). Abstracts of the 5th Meeting of the European Association for Cancer Research, ViennaAustria, 1979, 49
   Google Scholar
• Wanebo HJ, Fukuda M, Tsuei L, et al. The leukocyte migration idubition response to certain breast cancer-related antigens (MCF-7 and MuMTV): Their potential as discriminants. Surgery 1979; 86: 275–283
   PubMed Web of Science ®Google Scholar
• Fukuda M, Wanebo HJ, Tsuei L, et al. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses. JNCl 1980; 64: 431–437
   PubMed Web of Science ®Google Scholar
• Crepin M, Lidereau R, Chermann JC, et al. Sequences related to mouse mammy tumor virus genome in tumor cells and lymphocytes from patients with breast cancer. Biochem Biophys Res Commun 1984; 118: 324–331
   PubMed Web of Science ®Google Scholar
• Fortt RW, Gibbs AR, Williams D, et al. The identification of “casein” in human breast cancer. Histopathology 1979; 3: 395–406
   PubMed Web of Science ®Google Scholar
• Papsidero LD. Immune complexes and tumor-Associated protein in human breast cancer. Diss Abstr Int [B] 1979; 39: 5837, 12. part 1
   Google Scholar
• Parthenais E, Haskill S. Immunity to the T 1699 murine mammary tumor. I. Thymic influence and long-term effect of irradiation on the humoral response. II. Thymic influence on the in situ inflammatory response. metastatic growth and invaqiveness. J Immunol 1979; 123: 1329–1333; 1334–1338
   PubMed Web of Science ®Google Scholar
• Taylor SA, Gordon MY, Currie GA, Shepherd VB. Irradiation and monocyte function in patients with breast cancer. Int J Radiat Oncol Biol Phys 1979; 5: 2063–2067
   PubMed Web of Science ®Google Scholar
• Eisman JA, Maclntyre I, Martin TJ, Moseley JM. 1, 25-dihydroxy-vitamin-D receptor in breast cancer cells. Lancet 1979; 2: 1335–1336
   PubMed Web of Science ®Google Scholar
• Jorgensen OG, Ekeland A, Gautvik KM. Serum and tissue concentrations of immunoreactive calcitonin in patients with breast tumors. Acta Endocrinol (Copenh) 1979; 92: 522–531
   PubMedGoogle Scholar
• McCulloch PB, Dent PB. Plasma CEA, serum ferritin and C reactive protein in carcinoma of breast. Compendium of Assays for Immunodiagnosis of Human Cancer Development in Cancer Research, RB. Herberman. Elsevier/North Holland Biomedical Press, New York 1979; 411–413
   Google Scholar
• Haagensen DE, Wells SA. Plasma human breast gross cystic disease fluid assay. Compendium of Assays for Immunodiagnosis of Human Cancer Development in Cancer Research, RB. Herberman. Elsevier/North Holland Biomedical Press, New York 1979; 397–405
   Google Scholar
• Searle F, Bagshawe KD. K-casein assay. Compendium of Assays for Immunodiagnosis of Human Cancer Development in Cancer Research, RB. Herberman. Elsevier/North Holland Biomedical Press, New York 1979; 407–410
   Google Scholar
• Bouillenne C, Deneufbourg JM. Positive correlation between breast cancer incidence and HLA antigens. Oncology 1979; 36: 156–159
   PubMed Web of Science ®Google Scholar
• Snoek M, Demand P. Analysis of the expression of H-2 and H-2-linked antigens on mammary tumor cells. Int J Cancer 1979; 24: 165–167
   PubMed Web of Science ®Google Scholar
• Nemoto T, Constantine R, Chu TM. Human tissue polypeptide antigen in breast cancer. J Natl Cancer Inst 1979; 63: 1347–1350
   PubMed Web of Science ®Google Scholar
• Bung JP, Edgington TS. Radioimmunoassay for tissue distribution of a human mammary tumor-specific glycoprotein. Cancer Res 1980; 40: 562–666
   Web of Science ®Google Scholar
• Check U, Cobb M, Hunter RL. The relationship between cyto-toxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast. Am J Pathol 1980; 98: 325–338
   PubMed Web of Science ®Google Scholar
• Kjellgren K. The prognastic significance of consecutive determinations of serum tissue polypeptide antigen (TPA) in human breast cancer. Carcino-Embryonic Proteins: Chemistry, Biology. Clinical Applimtions, FG. Lehmann. Elsevier/North Holland Biomedical Press, New York 1979; 607–610
   Google Scholar
• Witkin SS, Sarkar NH, Good RA, Day NK. An enzyme-linked immunoassay for the detection of antibodies to the mouse mammary tumor virus: Application to human breast cancer. J Immunol Methods 1980; 32: 85–91
   PubMed Web of Science ®Google Scholar
• Wiseman CL, Bowen JM, Davis JW, et al. Human lymphocyte blastogenesis responses to mouse mammary tumor virus. JNCI 1980; 64: 425–430
   PubMed Web of Science ®Google Scholar
• Recklies AD, Tiltman KJ, Stoker MA, Poole AR. Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res 1980; 40: 550–556
   PubMed Web of Science ®Google Scholar
• Higuchi M, Robinson DS, Cailleau R, et al. A serologic study of cultured breast cancer cell lines: Lack of antibody response to tumor specific membrane antigens in patients. Clin Exp Immunol 1980; 39: 190–96
   PubMed Web of Science ®Google Scholar
• Konorza GG, Muller P, Klein PJ, Krueger GR. Local B-cell immune response in breast cancer; relationship with presence of Thomsen-Friedenreich antigen (TF) (meeting abstract). Br J Cancer 1979; 39: 1482–483
   Web of Science ®Google Scholar
• Springer GF, Desai PR, Murthy MS, et al. Human carcioma-associated precursor antigens of the blood group MN system and the host's immune responses to them. Prog Allergy 1979; 26: 42–96
   PubMedGoogle Scholar
• Springer GF, Desai PR, Murthy MS, et al. Precursors of the blood group MN antigens as human carcinoma-Associated antigens. Transfusion 1979; 19: 233–249
   PubMed Web of Science ®Google Scholar
• Thomson DM, Tataryn DN, Schwartz R. Partial purification of organ-specific neoantigens from human colon and breast cancer by affinity chromatography with human tumor-specific gamma-globulin. Br J Cancer 1980; 41: 86–99
   PubMed Web of Science ®Google Scholar
• Inaba N, Renk T, Daume E, Bohn H. Ectopic production of placenta-specific tissue proteins (PP5 and PP11) by malignant breast tumors. Arch Gynecol 1981; 231: 87–90
   PubMedGoogle Scholar
• Foster CS, Dinsdale EA, Edwards PA, Neville AM. Monoclonal antibodies to the human mammary gland. II. Distribution of determinants in breast carcinomas. Virchows Arch 1982; 349: 295–305
   Web of Science ®Google Scholar
• Smith S, Pasco D, Pawiak J, et al. Thioesterase II, a new marker enzyme for human cells of breast epithelial origin. JNCI 1984; 73: 323–329
   PubMed Web of Science ®Google Scholar
• Coulson PB, Thornthwaite JT, Woolley TW, et al. Prognostic indicators including DNA histogram type, receptor content and staging related to human breast cancer patient survival. Cancer Res 1984; 44: 4187–4196
   PubMed Web of Science ®Google Scholar
• Caffier H, Brandau H. Serum tumor markers in metastatic breast cancer and course of disease. Cancer Detect Rev 1983; 6: 451–457
   PubMedGoogle Scholar
• Avdeev GI, Iakubovskaia RI, Aleksander SK, et al. Antigenic structure of normal and malignant breast tissue. Vopr Onkol 1983; 29: 33–37
   PubMed Web of Science ®Google Scholar
• Balinsky D, Platz CE, Lewis JW. lsozyme patterns of normal, benign and malignant human breast tissues. Cancer Res 1983; 43: 5895–5901
   PubMed Web of Science ®Google Scholar
• Ryan ED, Bilols G. Serum 5 '-nuclectidase: automation of a manual assay and brief dservations on values in patients with breast cancer. Clin Biochem 1983; 16: 249–253
   PubMed Web of Science ®Google Scholar
• Schapira DV, Schapira M. Use of ceruloplasmin levels to monitor response to therapy and predict recurrence of breast cancer. Breast Cancer Res Treat 1983; 3: 221–224
   PubMed Web of Science ®Google Scholar
• Forbes JF, Clunie G, Braithwaite P, et al. Breast cancer genetics: the continuing search for a marker indicating susceptibility. In-ternatl. Assoc. Breast Cancer Res. Colorado 1983, 1983 meeting abstract number A10
   Google Scholar
• Winkel P, Statland BE, Mouridsen H, et al. The value of routine biochemical and surgical pathology quantities in predicting recurrence in high-risk patients following surgery for primary breast cancer. Am J Clin Pathol 1983; 80: 822–827
   PubMed Web of Science ®Google Scholar
• Dalifard I, Daver A, Cellier P, Larra F. What value should be given to assays of serum ferritin in breast cancers? Correlation with various biological parameters. Sem Hop Paris 1984; 60: 157–162
   PubMedGoogle Scholar
• Wurz H, Luben G, Bohn H. Serum levels of placental protein 10 (PP10) in women with breast cancer and genital carcinoma and in healthy male and female subjects. Arch Gynecol 1983; 233: 267–274
   PubMedGoogle Scholar
• Hollinshead A, Jaffurs W, Alpert L, Herbem RB. Specific soluble membrane antigen of malignant and normal breast cells: delayed hypersensitive skin reactions in cancer patients. Proc 2nd In-ternatl Sympos CancerDetec Prev, C. Maltoni. Excerpta Medica, Amsterdam 1973; 647–654, Congr Series, No. 322
   Google Scholar
• Hollinshead A, Jaffurs W, Alpert L, et al. Isolation and identification of soluble skin reactive membrane antigens of malignant and normal breast cells. Cancer Res 1974; 34: 2961–2968
   PubMed Web of Science ®Google Scholar
• Abstracts of Breast Cancer Task Force Committee Workshop: Monoclonal antibodies of Breast Cancer. NCI, Bethesda, MDUSA June 29, 1981
   Google Scholar
• Nuti M, Teramdo YA, Mariani-Costantini R., et al. A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carciorna cell populations. Int J Cancer 1982; 29: 539–545
   PubMed Web of Science ®Google Scholar
• Rainsbury RM, Ott RJ, Westwood JH, et al. Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-III. Lancet 1983; 2: 934–938
   PubMed Web of Science ®Google Scholar
• Menard S, Tagliabue E, Canevari S, et al. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res 1983; 43: 1295–1300
   PubMed Web of Science ®Google Scholar
• Sawtell NM, DiPersio L, Michael JG, et al. Expression of normal and tumor associated antigens in human breast carcinoma. Lab Invest 1984; 51: 225–232
   PubMed Web of Science ®Google Scholar
• Maloney T, Brenz R, Sale HD, McGrath CM. Reactivity of normal breast cells with monoclonal antibodies to breast cancer selective antigens ad estrophilin. Proc Ann Meet Am Assoc Cancer Res 1984; 25: 213
   Web of Science ®Google Scholar
• Ellis IO, Robins RA, Elston CW, et al. A monoclonal antibody, NCRC-II, raised to human breast carcinoma. 1. production and immunohistological characterization. Histopathology 1984; 831–516
   Web of Science ®Google Scholar
• Frankel A, Ring D, Kaplan D, Bjorn J. Selection of monoclonal antibodies for the development of breast cancer selective immunotoxins. Roc Am Assoc Cancer Res 1984; 25: 232
   Web of Science ®Google Scholar
• Harvey MA, Manning BD, Travis KL. High molecular weight glycoprotein antigens Associated with human breast carcinoma cells. Fed Proc 1984; 43: 1513
   Google Scholar
• Greiner JW, Hand PH, Noguchi P, et al. Enhanced expression of surface tumor-assoaated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment. Cancer Res 1984; 44: 3208–3214
   PubMed Web of Science ®Google Scholar